GINA CLARK: Open Payments
NPI 1124101332 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 101 payments from 23 companies in 2025. Trend: 2023 $881 · 2024 $1,211 · 2025 $1,493
Food & beverage: $1,493
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $286 |
| Novartis Pharmaceuticals Corporation | 16 | $229 |
| Amgen Inc. | 16 | $184 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $136 |
| ABBVIE INC. | 5 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Lilly USA, LLC | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Astellas Pharma US Inc | 3 | $52 |
| Corcept Therapeutics | 3 | $49 |
Products named: NURTEC ODT, LEQVIO, Kerendia, OTEZLA, JARDIANCE, REXULTI, CAPLYTA, UBRELVY.
Industry payments across KY — which companies pay providers there.
